Stargardt Disease Treatment 2025. According to the company, all three patients treated for two years or more have remained free of symptoms and disease progression while taking gildeuretinol. The drug is the first and only medicine to treat stargardt disease by targeting the underlying causes of the disease and reducing the rate of vitamin a dimerization.
There’s a tease 2, 3 and 4 study that i gave a little bit of an overview of, and the tease 2 program will have its top line release in early 2025 we expect. The main symptom of stargardt disease is loss of.